Chief Growth & Capital Officer

Chief Growth & Capital Officer at N-21.ai

N-21.ai is an early-stage healthcare AI startup dedicated to building agentic AI-driven managed outcomes platforms for Medicare Advantage and Medicaid. Our core mission is to enhance clinical outcomes, significantly reduce medical costs, and boost operational efficiency for payers and risk-bearing providers. We operate at the dynamic intersection of AI innovation, risk adjustment, value-based care, and managed care economics.

Role Overview

The Chief Growth & Capital Officer (CGCO) at N-21.ai is a pivotal seed-stage, C-level executive role. This individual will be directly responsible for revenue creation, strategic market entry, and early capital formation. This is a highly hands-on growth builder position, encompassing enterprise sales, robust business development, and critical fundraising responsibilities. The CGCO will collaborate closely with the Chairman & CEO to establish compelling commercial credibility, secure foundational 'lighthouse' customers, and strategically prepare the company for a successful Series A funding round.

Core Mandate

• Personally close the first few enterprise customers, driving significant market traction, sales, and overall company growth.
• Establish clear commercial proof points and a compelling ROI narrative for our solutions.
• Shape optimal pricing strategies and innovative outcomes-linked contracting models.
• Lead critical seed extension or Series A readiness fundraising efforts.
• Position N-21.ai credibly and attractively with both investors and strategic partners.

Key Responsibilities

Revenue & Sales Leadership:

• Lead founder-level enterprise sales targeting MA plans, Medicaid MCOs, risk-bearing providers, MSOs, and other key entities.
• Successfully convert pilot programs into multi-year platform contracts, establishing and driving Annual Recurring Revenue (ARR) models.
• Design the early Go-To-Market (GTM) motion and define the ideal customer profile.

Business Development & Partnerships:

• Identify and cultivate early strategic partners and co-sell opportunities.
• Support strategic entry into priority states and lines of business.

Capital Raise & Investor Engagement:

• Lead comprehensive seed extension and Series A fundraising efforts.
• Own and articulate the investor narrative, focusing on outcomes, ROI, and AI leverage.
• Manage investor meetings, diligence processes, and pitch materials with executive precision.

Executive Leadership:

• Act as a core and influential member of the executive leadership team.
• Provide crucial support for board communication and overarching strategic planning.

Success Metrics (First 12–18 Months)

• Achieve $2–5M ARR with MA / Medicaid customers.
• Secure 2–4 lighthouse logos.
• Establish clear outcomes-based ROI proof points.
• Define a repeatable early GTM motion.
• Successfully complete or de-risk Series A fundraising.

Ideal Candidate Profile

Experience:

• 10+ years of robust experience in healthcare sales, growth, or corporate development.
• Direct, proven experience selling to MA plans, Medicaid MCOs, or risk-bearing providers.
• Prior experience within an early-stage healthcare or health-tech startup environment.
• Exposure to venture fundraising (seed or Series A rounds).

Domain Expertise:

• Strong, in-depth understanding of MA and Medicaid economics.
• Familiarity with risk adjustment, quality metrics, utilization management, and value-based care frameworks.
• Demonstrated ability to translate complex AI and clinical value propositions into compelling CFO-level ROI narratives.

Leadership Traits:

• Possess a 'player-coach' mentality, ready to both lead and execute hands-on.
• Comfortable and effective operating with ambiguity in a fast-paced environment.
• Exhibit a strong executive presence, capable of engaging confidently with both customers and investors.
• Outcome-driven and commercially sharp with a keen business acumen.

Compensation & Equity

• Competitive seed-stage executive base salary.
• Meaningful equity participation, directly aligned with company growth and success.
• Performance-linked incentives tied to revenue and fundraising milestones.

Why This Role Matters

This is a foundational sales executive role with a direct and significant impact on N-21.ai's revenue trajectory, company valuation, and investor confidence. The Chief Growth & Capital Officer will be instrumental in shaping the company’s commercial identity and strategically positioning it for successful Series A scale and beyond.

Key skills/competency

• Enterprise Sales
• Business Development
• Capital Fundraising
• Go-To-Market Strategy
• Managed Care Economics
• Medicare Advantage
• Medicaid
• Risk Adjustment
• Value-Based Care
• Investor Relations